Treatment advances for advanced bladder cancer has not been there in the past 30 years, but scientists from Queen Mary University of London have made a breakthrough in developing a new therapy. Published today in iNature/i, the study examined an antibody (MPDL3280A) which blocks a protein (PD-L1) thought to help cancer cells evade immune detection. In a phase one, multi-centre international clinical trial, 68 patients with advanced bladder cancer (who had failed ...
via Medindia Health News
More READ
No comments:
Post a Comment